{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:57Z","timestamp":1786119237038,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/iae.0b013e3181a3b848","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T16:45:30Z","timestamp":1242924330000},"page":"579-585","source":"Crossref","is-referenced-by-count":40,"title":["CONCENTRATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN AQUEOUS HUMOR OF EYES WITH ADVANCED RETINOPATHY OF PREMATURITY BEFORE AND AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB"],"prefix":"10.1097","volume":"29","author":[{"given":"NORIE ITO","family":"NONOBE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHU","family":"KACHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINEO","family":"KONDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIKO","family":"TAKAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOJI","family":"TAKEMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ATSUSHI","family":"NAKAYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAHIRO","family":"HAYAKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROKO","family":"TERASAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor.","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.","volume":"118","author":"Adamis","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia.","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ophtha.2005.01.043","article-title":"Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.","volume":"112","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmology"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.iae.0000225351.87205.69","article-title":"Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.","volume":"26","author":"Chen","year":"2006","journal-title":"Retina"},{"key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archopht.125.10.1363","article-title":"Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.","volume":"125","author":"Sawada","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R11-3-20210130","first-page":"600","article-title":"Retinopathy of prematurity in extremely low birth weight infants: a Tokyo multicenter study.","volume":"108","author":"Hiraoka","year":"2004","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.","volume":"245","author":"Chung","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)65004-3","article-title":"Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.","volume":"156","author":"Lashkari","year":"2000","journal-title":"Am J Pathol"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archopht.1987.01060070042025","article-title":"An international classification of retinopathy of prematurity, II: the classification of retinal detachment.","volume":"105","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.eye.6702213","article-title":"Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.","volume":"21","author":"Funatsu","year":"2007","journal-title":"Eye"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-200905000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:25Z","timestamp":1786038505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200905000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181a3b848","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}